top of page

Understanding AYVAKIT: a treatment option for adults with ISM and AdvSM ~ August 7th, 2024

Presented (on behalf of Blueprint Medicines) by:

James McCloskey, MD Chief,

Division of Leukemia John Theurer Cancer Center



Wednesday, August 07, 2024,

6:00 PM EDT

Grill 23 & Bar

161 Berkeley St Boston, MA, 02116


Join us for a promotional education speaker program about AYVAKIT® (avapritinib).

During this program, you will hear from an expert who will discuss the following topics:

  •   Disease State Background and Burden of Disease

  •   AYVAKIT for the Treatment for Adults With Indolent Systemic Mastocytosis

  •   AYVAKIT for the Treatment for Adults With Advanced Systemic Mastocytosis


You may register for this program by calling or texting Sharon Lively at (508) 277-8777 or emailing slively@blueprintmedicines.com.




40 views0 comments

Comments


bottom of page